Why is Senores Pharma. falling/rising?

As of 25-Jul, Senores Pharmaceuticals Ltd is currently priced at 668.10, reflecting a decrease of 10.55 points or 1.55%. The stock has shown a strong performance over the past week and month, with returns of 6.79% and 16.81%, respectively. However, today's trading has seen the stock underperform its sector by 1.02%, with an intraday high of Rs 704 and a low of Rs 664.7. Despite trading above all key moving averages, the stock's weighted average price indicates more volume was traded closer to the low price. Additionally, while the company has demonstrated healthy long-term growth with significant increases in net sales and operating profit, it faces challenges such as a high valuation reflected in its Price to Book Value and a decrease in institutional investor participation.
Broader market context shows that while Senores Pharmaceuticals has outperformed the Sensex over the past week and month, the benchmark has shown a slight decline of 0.36% and 1.56%, respectively. The stock's year-to-date return of 17.44% also surpasses the Sensex's 4.25% gain. However, the recent drop in institutional investor stakes may indicate a lack of confidence among more sophisticated investors, which could contribute to the stock's current downward movement despite its strong fundamentals and growth potential.